Clinical trial Recruiting at 2 sites Interventional Ages 75 to 110

Personalized care plan to prevent functional decline in elderly diabetics

Official title: Prevention of Functional Decline by Multimodal Intervention in Older Patients With Diabetes

Run by University of Cagliari · NCT06842459 · Data updated 2026-11-12

This study tests if a personalized care plan can help older people with diabetes stay active and healthy compared to regular care.

Quick facts

Study typeInterventional
Ages75 Years to 110 Years
SexAll
Enrollment180 (estimated)
SponsorUniversity of Cagliari
Academic / other
Locations2 sites (Cagliari, Cagliari and 1 other locations)
StatusRecruiting
StartedFebruary 3, 2025
Main results expectedOctober 2026
Study endsOctober 2026
Registry record updatedFebruary 24, 2025
Trial IDNCT06842459 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are diabetic patients aged 75 years and older who exhibit some functional limitations.

Probably not a fit

Patients with severe disabilities in daily living activities or those with significant cognitive impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates whether a personalized care plan based on Comprehensive Geriatric Assessment (CGA) can reduce the risk of functional decline in older patients with diabetes compared to usual care. It involves a randomized controlled trial with 180 participants aged 75 and older, focusing on their functional status and patient-centered outcomes. The study is conducted across three hospitals in Italy, aiming to address the unique challenges faced by elderly diabetic patients, including the risk of disability and functional loss.

Why it matters

Potential benefit: If successful, this approach could significantly improve the quality of life and functional independence for elderly patients with diabetes.

How similar studies have gone: Other studies have shown promise in using comprehensive geriatric assessments to improve outcomes in older populations, suggesting this approach may be beneficial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Age ≥75 years;
* Diagnosis of diabetes mellitus;
* Functional limitation defined as a Short Physical Performance Battery (SPPB) score between 4 (included) and 9 (included), and
* Willingness to participate in the study.

Exclusion criteria:

* Severe disability in basic activity of daily living (dependency in 3 or more activities),
* Not being resident in the hospital catchment area; residence in long-term care;
* Diagnosis of schizophrenia, other psychotic or bipolar disorder, or severe cognitive impairment (MMSE score \< 21/30);
* Alcohol abuse (\> 14 drinks per week);
* Cancer requiring treatment in the past 3 years, except for non-melanoma skin cancers or cancers that have an excellent prognosis (e.g., the early stage breast or prostate cancer);
* Respiratory insufficiency requiring regular use of supplemental oxygen;
* Recent (\< 6 months) myocardial infarction;
* Class IV NYHA heart failure;
* Severe chronic kidney disease (stage V, dialysis);
* Decompensated liver cirrhosis;
* Inability or unwillingness to provide informed consent.

Where it's running

  • Azienda Ospedaliero-Universitaria di Cagliari
    Cagliari, Cagliari, Italy
    Recruiting
  • Azienda Ospedaliero-Universitaria
    Cagliari, Cagliari, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.